← Browse by Condition
Medical Condition
inflammatory bowel diseases
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for inflammatory bowel diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — inflammatory bowel diseases Clinical Trials
How many clinical trials are currently recruiting for inflammatory bowel diseases?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for inflammatory bowel diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for inflammatory bowel diseases?
inflammatory bowel diseases research spans Phase 1 (1 trial), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a inflammatory bowel diseases clinical trial?
Eligibility criteria for inflammatory bowel diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 4
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07219537
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT07349472 Phase 2
Recruiting
Enrollment
60 pts
Location
Egypt
Sponsor
Ihab Elsayed Hassan
NCT07033208
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT03589183
Recruiting
Enrollment
1,500 pts
Location
South Korea
Sponsor
Kyunghee University Medical Ce...
NCT06309017
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
NYU Langone Health
NCT04970446 Phase 1, Phase 2
Recruiting
Enrollment
120 pts
Location
Australia
Sponsor
St Vincent's Hospital Melbourn...
NCT04280510
Recruiting
Enrollment
200 pts
Location
France
Sponsor
Institut National de la Santé ...
NCT05733702
Recruiting
Enrollment
100 pts
Location
Luxembourg
Sponsor
Luxembourg Institute of Health
NCT06226883 Phase 2
Recruiting
Enrollment
385 pts
Location
United States, Austr...
Sponsor
Morphic Therapeutic, Inc. (A W...
NCT07513181 Phase 2
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Athos Therapeutics Inc
NCT06065228
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
Children's National Research I...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology